VivoSeq
Cardiovascular

Orthostatic; Hypotension, Neurogenic

2

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Orthostatic; Hypotension, Neurogenic is an early-stage landscape with 2 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

N/A

Attrition Rate

0/100

Pipeline

Programs by Phase

Preclinical2

Placebo Pill

Vanderbilt University Medical Center

Midodrine or Atomoxetine Pill

Vanderbilt University Medical Center

Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs

Analysis

Trial Status

1

clinical trials

Recruiting1 · 100%

Clinical Trials

Trial Activity

Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms
Recruiting·VVanderbilt University Medical Center·Preclinical·NCT04782830·29 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)